Human Longevity Inc.
4570 Executive Drive
56 articles about Human Longevity Inc.
Human Longevity, Inc., built by the pioneers of the human genome sequencing effort, and Freedom Acquisition I Corporation, a publicly traded special purpose acquisition company, announced that they have signed a non-binding letter of intent for a proposed business combination that would result in HLI becoming a publicly listed company.
C. Thomas Caskey, MD, FACP, FACMG, FRSC and Professor, Molecular & Human Genetics at the Baylor College of Medicine, leads HLI’s team to expand genetic assessments to worldwide client base
Human Longevity Closes $30 Million Financing From Emerging Technology Partners and Other Leading Healthcare Investors to Renew Its Commitment to Longevity and Precision Health
Human Longevity, Inc. (“HLI”), an innovator in providing data-driven precision health intelligence platform for physicians and patients, today announced a $30 million financing from veteran biotech investment firms and investors
The area is home to numerous well-known players in the pharma industry, including Abbott, Iovance, Gossamer Bio, Crown Biosciences, Illumina, Human Longevity and many, many more.
It’s been a busy week for biopharma companies to name a chief executive officer. Over the past week, multiple companies have selected individuals to hold the top spots and guide the growth strategies of their companies.
La Jolla, California-based Human Longevity, Inc. (HLI) filed a lawsuit against the J. Craig Venter Institute (JCVI). Although Venter himself is at the center of the suit, he is not personally being sued.
Saturnino “Nino” Fanlo, chief financial officer and chief operations officer of Human Longevity (HLI), has left the company. Fanlo was implicated in a scandal at his previous employer, online lender Social Finance (SoFi).
Human Longevity Appoints Dr. David Karow, M.D., Ph.D., As Interim Chief Executive Officer, Invigorating Company's Vision To Drive Health Intelligence
Leadership Team Refined and Strengthened.
There have been a number of leadership changes in the life sciences industries over the past week. BioSpace compiled a roundup of the changing landscape of the c-suite and boards of directors across the industry.
The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to Human Longevity Clinical Labs LLC, San Diego, California, based on results of a recent on-site inspection as part of the CAP's Accreditation Programs.
HNX And HNX Platinum Offer Clients Comprehensive Health Experience And Follow On Testing.
Human Longevity, Inc. Hires Former Ancestry Executive, Scott Sorensen, As New Chief Technology Officer
Human Longevity, Inc. announced that Scott Sorensen is joining the leadership team as Chief Technology Officer, reporting to J. Craig Venter, Ph.D., Co-Founder, Chairman and CEO.
Human Longevity Release: New Metabolomic and Genomic-Informed Study Shows Use of Acetaminophen Has Unexpected Effects on Regulation of Sex Hormones
The study, published in the journal EBioMedicine, highlights the power of genomic and metabolomic profiling to better understand drug mechanisms of action and metabolism even in common drugs such as acetaminophen.
Human Longevity and AMRA Partner to Provide Advanced Body Composition Profiling to HLI's Health Nucleus Clients
AMRA and Human Longevity have announced a new agreement that will see AMRA's body composition profiling added to HLI's premier health assessment, the Health Nucleus experience.
There's been a major shakeup in the executive team at Human Longevity.
Researchers From Human Longevity Use Whole Genome Sequence Data And Machine Learning To Identify Individuals Through Face And Other Physical Trait Prediction
Human Longevity Researchers Develop New Algorithm To Rapidly And Accurately Predict HLA Types Using Illumina Next Generation Sequencing Technology
Human Longevity Announces Agreement With Merck KGaA, Darmstadt, Germany To Engage In Cancer Biomarker Discovery In Advanced Melanoma